Primary Recommendations

Inspecs - EBITDA forecast to jump US$6m this year

July 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

When Bath-based Inspecs floated in 2020 its mainstay was the design and manufacture of frames for corrective eyewear as well as sunglasses at its own factories in China and Vietnam to a worldwide customer base. What made the company unusual was that as well as producing private label frames, it had also licenced in several brands. At the float, Inspecs raised £26.5m at 195p in order to complete acquisitions and a year later, it went on a shopping spree. Funded by a further placing of new shares to raise £64m at 210p, five deals were concluded, one substantial, broadening its geographical presence in Germany and the US, adding more brands and spectacle lenses to its repertoire and quadrupling sales to US$250m. By relocati ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Market Comment - July '23

SRT Marine - Record order intake

Inspecs - Q1 signals the corner is turned (May 2024)

Inspecs (February 2024)

Inspecs - Margins enhanced by moving Eschenbach acetate manufacture to Vietnam (January 2024)

Inspecs (October 2023)

Inspecs (August 2023)

Inspecs (May 2023)

Inspecs (February 2023)

Inspecs - Interesting new issue (March 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X